We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$53.7B
AUM Growth
-$2.95B
Cap. Flow
+$168M
Cap. Flow %
0.31%
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 12.06%
3 Healthcare 11.81%
4 Communication Services 9.87%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
L icon
501
Loews
L
$23.4B
$5.92M 0.01%
55,467
+24,150
+77% +$2.59M
IDCC icon
502
InterDigital
IDCC
$6.68B
$5.84M 0.01%
19,338
-4,528
-19% -$1.54M
TSCO icon
503
Tractor Supply
TSCO
$15.5B
$5.75M 0.01%
126,971
+8,377
+7% +$427K
ETSY icon
504
Etsy
ETSY
$7.65B
$5.73M 0.01%
114,694
+42,439
+59% +$2.32M
XYL icon
505
Xylem
XYL
$27.7B
$5.72M 0.01%
47,885
-5,315
-10% -$697K
WPC icon
506
W.P. Carey
WPC
$16.7B
$5.68M 0.01%
83,554
+993
+1% +$69.7K
RBC icon
507
RBC Bearings
RBC
$18.6B
$5.67M 0.01%
10,435
+8,625
+477% +$4.58M
TD icon
508
Toronto Dominion Bank
TD
$200B
$5.63M 0.01%
60,453
-10,900
-15% -$1.04M
CF icon
509
CF Industries
CF
$19.5B
$5.57M 0.01%
42,910
-7,146
-14% -$729K
MAZE
510
Maze Therapeutics
MAZE
$1.59B
$5.55M 0.01%
185,794
TRVI icon
511
Trevi Therapeutics
TRVI
$2.48B
$5.54M 0.01%
+464,746
New +$5.2M
RCUS icon
512
Arcus Biosciences
RCUS
$3.74B
$5.46M 0.01%
+252,933
New +$5.46M
CRDO icon
513
Credo Technology Group
CRDO
$42.4B
$5.46M 0.01%
58,157
-11,688
-17% -$1.42M
FSLR icon
514
First Solar
FSLR
$22.5B
$5.45M 0.01%
27,653
-963
-3% -$213K
CART icon
515
Maplebear
CART
$10.4B
$5.44M 0.01%
145,260
+31,410
+28% +$1.19M
PR
516
Permian Resources
PR
$18B
$5.41M 0.01%
253,835
+172,346
+211% +$2.98M
STT icon
517
State Street
STT
$50.7B
$5.39M 0.01%
42,614
+1,135
+3% +$145K
ACGL icon
518
Arch Capital
ACGL
$34.3B
$5.38M 0.01%
55,997
+19,813
+55% +$1.9M
NLY icon
519
Annaly Capital Management
NLY
$16.4B
$5.36M 0.01%
253,510
-23,197
-8% -$528K
PCAR icon
520
PACCAR
PCAR
$68.7B
$5.35M 0.01%
46,331
+14,578
+46% +$1.76M
CWST icon
521
Casella Waste Systems
CWST
$5.74B
$5.34M 0.01%
67,329
+8,334
+14% +$799K
SABS icon
522
SAB Biotherapeutics
SABS
$275M
$5.27M 0.01%
+1,375,610
New +$5.49M
APTV icon
523
Aptiv
APTV
$12.3B
$5.26M 0.01%
75,739
+10,665
+16% +$822K
JBL icon
524
Jabil
JBL
$33.5B
$5.2M 0.01%
19,562
+2,093
+12% +$527K
GH icon
525
Guardant Health
GH
$19.8B
$5.19M 0.01%
56,211
+8,249
+17% +$828K

Similar funds

Ensign Peak Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
  • Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
  • Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
  • Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
  • Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
  • Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.